Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring ...

The correction is one of the largest in Abbott's recent continuous glucose monitor business, which dominates the global ...

Abbott just announced a “medical device correction” for approximately three million glucose sensor monitors in the U.S., ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may ...

Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...

These companies have already handsomely rewarded longtime shareholders, and it's not too late to join the party.

Dividend-paying stocks are great for the passive income they provide to those who choose to take their payouts in cash, and ...

Now, it’s worth noting Stock Advisor’s total average return is 1,035% — a market-crushing outperformance compared to 191 % ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and ...

Global Insulin Delivery Device Market Growth Overview The global insulin delivery device market is poised to expand at a CAGR of around 8% during the forecast period, driven by the increasing global ...

Former UK Prime Minister Theresa May recounted her own experience of being diagnosed with diabetes while addressing Malta's parliament on Saturday, urging lawmakers to improve public understanding of ...

The global Blood Glucose Monitoring System Market, valued at US$15.16 billion in 2024, stood at US$16.46 billion in 2025 and is projected to ...